Literature DB >> 10448815

Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius.

B R Walker1, A Easton, K Gale.   

Abstract

PURPOSE: The nucleus of the solitary tract (NTS) is a primary site at which vagal afferents terminate. Because afferent vagal nerve stimulation has been demonstrated to have anticonvulsant effects, it is likely that changes in synaptic transmission in the NTS can regulate seizure susceptibility. We tested this hypothesis by examining the influence of gamma-aminobutyric acid (GABA) ergic and glutamatergic transmission in the NTS on seizures evoked by systemic and focal bicuculline and systemic pentylenetetrazol (PTZ) in rats.
METHODS: Muscimol (256 pmol), a GABA(A)-receptor agonist, bicuculline methiodide (177 pmol), a GABA(A)-receptor antagonist, kynurenate (634 pmol), a glutamate-receptor antagonist, or lidocaine (100 nl; 5%), a local anesthetic, was microinjected into the mediocaudal (m)NTS. Ten minutes later, seizure activity was induced by either a focal microinfusion of bicuculline methiodide (177 pmol) into the rostral piriform cortex, systemic PTZ (50 mg/kg, i.p.), or systemic bicuculline (0.35 mg/kg, i.v.).
RESULTS: Muscimol in mNTS (but not in adjacent regions of NTS) attenuated seizures in all seizure models tested, whereas bicuculline methiodide into mNTS did not alter seizure responses. Kynurenate infusions into mNTS significantly reduced the severity of seizures evoked both systemically and focally. Anticonvulsant effects also were obtained with lidocaine application into the same region of mNTS. Unilateral injections were sufficient to afford seizure protection.
CONCLUSIONS: Our results demonstrate that an increase in GABA transmission or a decrease in glutamate transmission in the rat mNTS reduces susceptibility to limbic motor seizures. This suggests that inhibition of mNTS outputs enhances seizure resistance in the forebrain and provides a potential mechanism for the seizure protection obtained with vagal stimulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448815     DOI: 10.1111/j.1528-1157.1999.tb00818.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  20 in total

1.  Trigeminal nerve stimulation modulates brainstem more than cortical excitability in healthy humans.

Authors:  B Mercante; G Pilurzi; F Ginatempo; A Manca; P Follesa; E Tolu; F Deriu
Journal:  Exp Brain Res       Date:  2015-08-11       Impact factor: 1.972

Review 2.  Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children.

Authors:  Mony Benifla; James T Rutka; William Logan; Elizabeth J Donner
Journal:  Childs Nerv Syst       Date:  2006-07-01       Impact factor: 1.475

Review 3.  Anatomo-Physiologic Basis for Auricular Stimulation.

Authors:  Beniamina Mercante; Francesca Ginatempo; Andrea Manca; Francesco Melis; Paolo Enrico; Franca Deriu
Journal:  Med Acupunct       Date:  2018-06-01

Review 4.  The Vagus Nerve in Appetite Regulation, Mood, and Intestinal Inflammation.

Authors:  Kirsteen N Browning; Simon Verheijden; Guy E Boeckxstaens
Journal:  Gastroenterology       Date:  2016-12-15       Impact factor: 22.682

5.  Transcutaneous Vagus Nerve Stimulation Modulates Default Mode Network in Major Depressive Disorder.

Authors:  Jiliang Fang; Peijing Rong; Yang Hong; Yangyang Fan; Jun Liu; Honghong Wang; Guolei Zhang; Xiaoyan Chen; Shan Shi; Liping Wang; Rupeng Liu; Jiwon Hwang; Zhengjie Li; Jing Tao; Yang Wang; Bing Zhu; Jian Kong
Journal:  Biol Psychiatry       Date:  2015-04-02       Impact factor: 13.382

6.  [Results of vagus nerve stimulator implantation in children and adolescents with treatment-refractory epilepsy].

Authors:  Kim Vanessa Steinke; Hartmut Möbius; Hans-Jürgen Christen; Hans-Jürgen Welkoborsky
Journal:  HNO       Date:  2022-04-12       Impact factor: 1.284

7.  Meta-analysis of vagus nerve stimulation treatment for epilepsy: correlation between device setting parameters and acute response.

Authors:  S Ghani; J Vilensky; B Turner; R S Tubbs; M Loukas
Journal:  Childs Nerv Syst       Date:  2015-10-22       Impact factor: 1.475

Review 8.  Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic.

Authors:  Kerry J Ressler; Helen S Mayberg
Journal:  Nat Neurosci       Date:  2007-09       Impact factor: 24.884

9.  Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model.

Authors:  Jarogniew J Luszczki; Remigiusz Czernecki; Katarzyna Wojtal; Kinga K Borowicz; Stanislaw J Czuczwar
Journal:  J Neural Transm (Vienna)       Date:  2008-04-01       Impact factor: 3.575

10.  Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy.

Authors:  Christopher M DeGiorgio; Jason Soss; Ian A Cook; Daniela Markovic; Jeffrey Gornbein; Diana Murray; Sandra Oviedo; Steven Gordon; Guadalupe Corralle-Leyva; Colin P Kealey; Christi N Heck
Journal:  Neurology       Date:  2013-01-30       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.